There is no FDA-approved Selank dosage and no controlled evidence defining Selank withdrawal. Small Russian studies reported intranasal regimens, including 2,700 micrograms per day in 20 people with generalized anxiety disorder. That is a study amount, not a general protocol, and the available trials are too small to establish either long-term safety or a discontinuation syndrome.
What Selank dosage appears in human research?
The most explicit accessible human regimen is 2,700 mcg per day intranasally in a 20-person generalized-anxiety study. A single 900 mcg exposure was also used to examine early EEG response. The study reported rapid and conventional response patterns over 14 days, but had no placebo comparison described in the abstract and was presented as a congress report.
Why 2,700 mcg per day is not a standard Selank dose
One small study can show what researchers administered; it cannot define the dose for every intended use. A standard regimen would need replicated dose-ranging trials, a specified and reproducible nasal product, adverse-event data large enough to detect uncommon harms, and clear instructions for missed doses, duration and discontinuation. Selank has none of that in an FDA-reviewed label.
The 60-person comparative study reported anxiolytic effects and said the effect persisted for a week after the last administration. It does not supply a complete dose in the English abstract and does not answer whether repeated or longer use changes discontinuation risk. Filling those gaps with a vendor protocol would turn missing evidence into false precision.
Does Selank cause withdrawal?
No published human trial located here formally tested withdrawal after Selank. That means a withdrawal syndrome has not been established; it does not prove that withdrawal cannot occur. The available trials were small, short and focused on anxiety outcomes rather than systematic discontinuation monitoring.
The report that benefit lasted for a week after the last dose is sometimes presented as proof of “no withdrawal.” It is not. Persistence of an average measured effect and absence of individual discontinuation symptoms are separate outcomes. Without a planned withdrawal phase, symptom checklist and adequate follow-up, the second question remains unanswered.
What did the alcohol-withdrawal study test?
Researchers gave alcohol-dependent rats a single 0.3 mg/kg intraperitoneal injection during a model of acute alcohol withdrawal. They reported reduced anxiety-like behavior and mechanical allodynia. The experiment did not use a nasal spray, did not involve human participants and did not test withdrawal from Selank itself.
An animal mg/kg number cannot be copied to a person. Species, route, formulation and endpoint all change at once. Anyone in alcohol withdrawal needs medical assessment because severe withdrawal can be an emergency; this animal paper does not support substituting Selank for established care.
Is Selank FDA approved?
No. Selank is not a component of an FDA-approved drug. The FDA's current compounding-risk page lists Selank acetate among withdrawn nominations and says compounded products may pose immunogenicity risk for some routes because of aggregation or peptide-related impurities. It also says important information about human safety is lacking.
“Withdrawn nomination” does not mean approved or cleared. It means the nomination stopped; Selank did not move onto the 503A bulks list. A nasal bottle sold online therefore does not gain an FDA-reviewed identity, concentration, pump output or safety profile from the word “compounded.”
How should Selank nasal-spray amounts be checked?
The arithmetic is concentration multiplied by pump volume. Both values must be verified. For example, 3,000 mcg/mL delivered in a calibrated 0.1 mL actuation equals 300 mcg per spray. A different pump volume changes the amount even when the bottle concentration stays the same.
- Look for micrograms or milligrams per millilitre, not only a bottle total.
- Find the metered volume per actuation from the actual device.
- Do not assume every drop or spray is 0.1 mL.
- Keep study route and species attached to every number.
That calculation audits what a spray claims to contain; it does not decide what anyone should take. For the same distinction in injectable vials, see what a peptide calculator can and cannot know.